NasdaqGS - Nasdaq Real Time Price USD

Sight Sciences, Inc. (SGHT)

Compare
3.9000 -0.0100 (-0.26%)
At close: December 11 at 4:00:01 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Paul Badawi Co-Founder, President, CEO & Director 871.59k -- 1975
Dr. David Badawi M.D. Founder, CTO & Director -- -- 1970
Ms. Alison Perry Bauerlein CFO & Treasurer 378.6k -- 1981
Mr. Matthew W. Link Chief Commercial Officer 157.61k -- 1975
Mr. Brenton Taylor Executive Vice President of Operations -- -- 1981
Mr. Jeremy B. Hayden J.D. Chief Legal Officer -- -- 1970
Mr. Steve R. Tamayo Jr. VP and Chief Ethics & Compliance Officer -- -- --
Dr. Reay H. Brown M.D. Chief Medical Officer -- -- --
Dr. Manohar Raheja Ph.D. Executive Vice President of Research & Development -- -- --
Mr. Stephen B. Thau J.D. Secretary -- -- --

Sight Sciences, Inc.

4040 Campbell Avenue
Suite 100
Menlo Park, CA 94025
United States
877 266 1144 https://www.sightsciences.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
214

Description

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Corporate Governance

Sight Sciences, Inc.’s ISS Governance QualityScore as of December 1, 2024 is 7. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 5, 2025 at 10:59 AM UTC - March 10, 2025 at 12:00 PM UTC

Sight Sciences, Inc. Earnings Date

Recent Events

December 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 3, 2024 at 8:30 PM UTC

at Piper Sandler Healthcare Conference

November 14, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

November 7, 2024 at 9:30 PM UTC

Q3 2024 Earnings Call

November 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 4, 2024 at 8:50 PM UTC

at Morgan Stanley Global Healthcare Conference

August 2, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 1, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers